Recent Regulatory 8-K events
Recent 8-Ks about regulator actions, exchange notices, compliance events, and approvals.
-
Rent the Runway gets Nasdaq notice on $15M minimum market value; 180 days to May 3, 2027
-
Nasdaq panel denies NextNRG listing appeal; trading suspended Nov 11, stock to OTC
-
Metagenomi wins FDA IND clearance for MGX-001 in hemophilia A; Q3 cash $101.7M runway into 2028
-
Cingulate expects CTx-1301 NDA resubmission in Dec 2026-Jan 2027 after CMC-only CRL
-
Gores Holdings X restates Q3 2025 EPS, cites $27.5M accretion error and material weakness
-
Larimar completes rolling BLA for nomlabofusp in Friedreich's ataxia; cash $128.7M
-
Aldeyra seeks FDA transfer of ADX-2191 PVRL review, withdraws SPA protocol
-
TMC says NOAA expects mid-December 2026 decision on seabed mining permit certification
-
Vistagen says FDA Type C feedback supports LSAS endpoint path for fasedienol Phase 3 in SAD
-
Future Vision II regains Nasdaq minimum public holders compliance; Nov. 5 notice closes the matter
-
Netcapital receives Nasdaq exception; must file delinquent 10-K and 10-Q by Feb 9, 2027
-
FDA issues Not Approvable Letter for Novocure's Optune Mya PMA in NSCLC brain metastases
-
Knightscope receives Nasdaq minimum bid deficiency letter; 180-day clock runs to May 3, 2027
-
reAlpha stockholders approve reverse split range, Prevu and InstaMortgage share issuances
-
Curis gets Nasdaq delisting determination after 30 days below $1.00; plans to appeal
-
Wisconsin regulators approve rate changes for WEC Energy utilities
-
Fifth Era Acquisition Corp I gets Nasdaq extension to March 15, 2027 to meet 400-holder rule
-
Barfresh (BRFH) gets Nasdaq minimum-bid notice; must hold $1.00 by May 4, 2027 or face delisting
-
MineralRite says FINRA processed Form 211, letting sponsor begin priced OTC quotations in RITE
-
BioCardia completes PMDA consultation for CardiAMP, advancing toward Japan marketing approval filing
-
Tempest Therapeutics gets Nasdaq bid-price notice; TPST has until May 3, 2027 to top $1.00
-
Pantages Capital wins Nasdaq extension to March 1, 2027 to reach 400 total holders
-
Sports Entertainment Gaming Global regains Nasdaq compliance after late Q2 10-Q filing
-
Local Bounti wins NYSE extension to Aug 5, 2027 to cure $50M market-cap listing deficiency
-
Cognition Therapeutics gets Nasdaq bid-price deficiency notice; Q3 net loss narrows to $4.1M
-
Bioxytran secures attested Free Sale Certificate for A-SUQAR, targeting UAE and Gulf markets
-
Intrusion wins Nasdaq's second 180-day extension until May 3, 2027 to cure sub-$1 bid
-
Bio Green Med gets Nasdaq bid-price notice; 180 days to April 27, 2027 to top $1.00
-
Malibu Boats stockholders approve charter amendments, elect directors, and ratify KPMG
-
Bayview Acquisition Corp to be delisted by Nasdaq after missing June 19 Oabay deal deadline
-
Viking Global's VKIN-300 wins French LNE Attestation of Conformity No. 41506-0, valid to Oct 2031
-
FDA Confirms SeaStar Medical's QUELIMMUNE SAVE Registry Fulfilled Post-Approval Requirements
-
Ribbon Acquisition (RIBB) gets Nasdaq notice over $35M minimum market value shortfall
-
Spire Missouri seeks $228M revenue increase in first future-test-year rate case
-
Our Bond (OBAI) regains Nasdaq $1.00 minimum bid price compliance after 10 straight days
-
House of Doge faces Nasdaq delisting as bid price stays at $0.10 or below for 10 days
-
NRx Pharma wins FDA approval of preservative-free ketamine ANDA, ahead of Nov 10 GDUFA goal date
-
Inovio wins FDA accelerated approval of VOCERYQ, first U.S.-approved DNA medicine, for RRP
-
Accendra Health gets NYSE notice over $50M market cap and equity listing standard
-
Vulcan unit Calmat gets MSHA imminent-danger order at Lexington Quarry; no injuries
-
Nasdaq moves to delist Parabolic Technologies after sub-$1 bid; authorized shares raised to 850M
-
Neumora gets Nasdaq bid-price notice; 180 days to regain $1.00 compliance by April 26, 2027
-
Game Your Game hit with Nasdaq $1.00 minimum-bid notice; cure deadline April 26, 2027